Literature DB >> 29413656

Precursor Lesions of the Low-Grade Breast Neoplasia Pathway.

Laura C Collins1.   

Abstract

The nonobligate precursor lesions columnar cell change/hyperplasia and flat epithelial atypia, atypical ductal hyperplasia and atypical lobular hyperplasia, lobular carcinoma in situ, and low-grade ductal carcinoma in situ share morphologic, immunophenotypic, and molecular features supporting the existence of a low-grade breast neoplasia pathway. The practical implication for pathologists is that the identification of one of these lesions should prompt careful search for others. From a clinical management perspective, however, their designation as "precursor lesions" should not be overemphasized, as the risk of progression among the earliest lesions is exceedingly low. Factors determining which lesions will progress remain unknown.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical ductal hyperplasia; Flat epithelial atypia; Lobular neoplasia; Low-grade breast neoplasia; Low-grade ductal carcinoma in situ; Tubular carcinoma

Mesh:

Substances:

Year:  2017        PMID: 29413656     DOI: 10.1016/j.path.2017.09.007

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  3 in total

1.  Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy - Surgeons' Practice.

Authors:  Sadaf Alipour; Ramesh Omranipour; Frederic Amant; Bita Eslami
Journal:  Eur J Breast Health       Date:  2020-01-01

2.  Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.

Authors:  Jonine D Figueroa; Gretchen L Gierach; Máire A Duggan; Shaoqi Fan; Ruth M Pfeiffer; Yihong Wang; Roni T Falk; Olivier Loudig; Mustapha Abubakar; Mindy Ginsberg; Teresa M Kimes; Kathryn Richert-Boe; Andrew G Glass; Thomas E Rohan
Journal:  Breast Cancer Res       Date:  2021-03-18       Impact factor: 6.466

Review 3.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.